Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU4-9P, or RNA, U4 small nuclear 9, pseudogene, is a pseudogene related to the U4 small nuclear RNA (snRNA) family, which plays a general role in the spliceosome machinery for pre-mRNA splicing, but as a pseudogene it is not believed to produce a functional RNA product[1]. No specific biological functions, disease associations, or direct interactions are described for RNU4-9P, and it is not recognized as a therapeutic target. The functionally active U4 snRNA genes (like RNU4-2) are essential for splicing and neurodevelopment, but there is no evidence that RNU4-9P has any such functional role. The designation "pseudogene" indicates it is an inactive genetic segment resembling a gene but lacking functional expression[1]. Notes: - RNU4-9P is not a protein-coding gene and is not considered a bona fide biological or therapeutic target[1]. - There are many functional homologs in the U4 snRNA family (e.g., RNU4-2), but RNU4-9P is designated specifically as a pseudogene and does not encode an active snRNA[1]. - No disease links, biomarker roles, drug interactions, or adverse safety information have been reported for RNU4-9P. If you meant a functional spliceosomal U4 snRNA gene (like RNU4-2), information would be very different: those are critical for splicing and implicated in neurodevelopmental disease[3]. For RNU4-9P specifically, this entry is not therapeutically or biologically active.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U4 small nuclear 9, pseudogene (RNU4-9P).